These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7804843)

  • 1. A ketamine mixture anesthetic inhibits neuroendocrine and behavioral consequences of cocaine administration.
    Torres G; Rivier C; Weiss F
    Brain Res; 1994 Sep; 656(1):33-42. PubMed ID: 7804843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes.
    Lu L; Liu Z; Huang M; Zhang Z
    J Neurochem; 2003 Mar; 84(6):1378-86. PubMed ID: 12614338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic cocaine administration sensitizes behavioral but not neuroendocrine responses.
    Borowsky B; Kuhn CM
    Brain Res; 1991 Mar; 543(2):301-6. PubMed ID: 1647834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of central and peripheral injection of interleukin-1 beta on brain c-fos expression and neuroendocrine functions.
    Rivest S; Torres G; Rivier C
    Brain Res; 1992 Jul; 587(1):13-23. PubMed ID: 1326374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for corticotropin-releasing factor in the long-term expression of behavioral sensitization to cocaine.
    Erb S; Brown ZJ
    Behav Brain Res; 2006 Sep; 172(2):360-4. PubMed ID: 16822557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine.
    Pierce RC; Kalivas PW
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1019-29. PubMed ID: 7473128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine.
    Kalivas PW; Alesdatter JE
    J Pharmacol Exp Ther; 1993 Oct; 267(1):486-95. PubMed ID: 8229779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical and behavioral responses to cocaine in adult male rats with neonatal isolation experience.
    Kosten TA; Zhang XY; Kehoe P
    J Pharmacol Exp Ther; 2005 Aug; 314(2):661-7. PubMed ID: 15845857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine responses to cocaine do not exhibit sensitization following repeated cocaine exposure.
    Levy AD; Li Q; Alvarez Sanz MC; Rittenhouse PA; Kerr JE; Van de Kar LD
    Life Sci; 1992; 51(12):887-97. PubMed ID: 1325586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior exposure to cocaine diminishes behavioral and biochemical responses to aversive conditioning: reversal by glycine/N-methyl-D-aspartate antagonist co-treatment.
    Morrow BA; Taylor JR; Roth RH
    Neuroscience; 1995 Nov; 69(1):233-40. PubMed ID: 8637621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MK-801 does not prevent acute stimulatory effects of amphetamine or cocaine on locomotor activity or extracellular dopamine levels in rat nucleus accumbens.
    Wolf ME; Xue CJ; White FJ; Dahlin SL
    Brain Res; 1994 Dec; 666(2):223-31. PubMed ID: 7882032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of behavioral sensitization to the cocaine-like fungicide triadimefon is blocked by pretreatment with AMPA, NMDA and DA D1 receptor antagonists.
    Reeves R; Thiruchelvam M; Cory-Slechta DA
    Brain Res; 2004 May; 1008(2):155-67. PubMed ID: 15145752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo.
    Tolliver BK; Newman AH; Katz JL; Ho LB; Fox LM; Hsu K; Berger SP
    J Pharmacol Exp Ther; 1999 Apr; 289(1):110-22. PubMed ID: 10086994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injection of SCH 23390 into the ventral tegmental area blocks the development of neurochemical but not behavioral sensitization to cocaine.
    Steketee JD
    Behav Pharmacol; 1998 Feb; 9(1):69-76. PubMed ID: 9832950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral expression of cocaine sensitization in rats is accompanied by a distinct pattern of modifications in the PKA/DARPP-32 signaling pathway.
    Scheggi S; Raone A; De Montis MG; Tagliamonte A; Gambarana C
    J Neurochem; 2007 Nov; 103(3):1168-83. PubMed ID: 17680995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral and neurochemical sensitization following cocaine self-administration.
    Hooks MS; Duffy P; Striplin C; Kalivas PW
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):265-72. PubMed ID: 7862906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentobarbital inhibits ketamine-induced dopamine release in the rat nucleus accumbens: a microdialysis study.
    Masuzawa M; Nakao S; Miyamoto E; Yamada M; Murao K; Nishi K; Shingu K
    Anesth Analg; 2003 Jan; 96(1):148-52, table of contents. PubMed ID: 12505941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and chronic corticotropin-releasing factor 1 receptor blockade inhibits cocaine-induced dopamine release: correlation with dopamine neuron activity.
    Lodge DJ; Grace AA
    J Pharmacol Exp Ther; 2005 Jul; 314(1):201-6. PubMed ID: 15784652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated injections of sulpiride into the medial prefrontal cortex induces sensitization to cocaine in rats.
    Steketee JD; Walsh TJ
    Psychopharmacology (Berl); 2005 Jun; 179(4):753-60. PubMed ID: 15619114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801.
    Koek W; Colpaert FC; Woods JH; Kamenka JM
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1019-27. PubMed ID: 2674416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.